APA (7th ed.) Citation

B, B., F, E., KS, R., B, v. T., S, T., VR, S., . . . EP, v. S. (2009). Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity. Clinical cancer research : an official journal of the American Association for Cancer Research, 15(16), 5108. https://doi.org/10.1158/1078-0432.CCR-09-0213

Chicago Style (17th ed.) Citation

B, Böll, et al. "Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF-kappaB and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell-mediated Cytotoxicity." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 15, no. 16 (2009): 5108. https://doi.org/10.1158/1078-0432.CCR-09-0213.

MLA (9th ed.) Citation

B, Böll, et al. "Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF-kappaB and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell-mediated Cytotoxicity." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 15, no. 16, 2009, p. 5108, https://doi.org/10.1158/1078-0432.CCR-09-0213.